Clinical Trial Update: Evaluation of Glycaemic Control Using GlucoTab® With Insulin Degludec in Hospitalized Patients With Diabetes Mellitus Type 2 [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial evaluating glycemic control using GlucoTab with insulin degludec in hospitalized patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GlucoTab (insulin glargine? wait)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Type 2 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED